{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Higue J"],"journal":["Blood cancer journal"],"pagination":["141"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371059"],"repository":["biostudies-literature"],"pubmed_title":["Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study."],"pmcid":["PMC12371059"],"pubmed_authors":["Delabesse E","Recher C","Flandrin-Gresta P","Hospital MA","Dumas PY","Orvain C","Couturier A","Bidet A","Carre M","Bertoli S","Chevallier P","Pastoret C","Cazaux M","Lachot S","Chantzi A","Aspas Requena G","Peterlin P","Tondeur S","Mozziconacci MJ","Higue J","Tavernier E","Pigneux A","Thepot S","Devillier R","Forcade E","Barriere S","Bouvier A","Veronese L"],"additional_accession":[]},"is_claimable":false,"name":"Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study.","description":null,"dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-08T10:48:21.417Z","creation":"2026-04-07T23:47:55.802Z"},"accession":"S-EPMC12371059","cross_references":{"pubmed":["40841520"],"doi":["10.1038/s41408-025-01344-3"]}}